GlobeNewswire by notified

VoltH2 Expands Management Team

Share

JERSEY CITY, N.J., Oct. 19, 2021 (GLOBE NEWSWIRE) -- via InvestorWire -- Vision Hydrogen Corporation (OTCQB:VIHD) (the “Company”) is pleased to announce that VoltH2, a Europe-based developer of green hydrogen production infrastructure projects that is 15.9% owned by the Company, has expanded its management team.

VoltH2 continues to make significant progress in realizing its objectives and has made a number of strategic hires, increasing its core team of highly experienced commercial and engineering professionals to 10 individuals, with a plan to double the team headcount by Q2 2022 as the pace of business continues to increase. Since commencing operation in early 2020, VoltH2 has been successfully executing on its mission to design, develop and build scalable hydrogen production facilities at multiple strategic locations in Western Europe. Deploying only proven and commercial technologies in partnership with established energy-industry participants, VoltH2 has been awarded permits for its initial electrolysis plant in Vlissingen, the Netherlands.

New hires include Paul Spoeltman, Head of Electrical Engineering; Bas Lavalaye, Commercial Manager focusing on business development and offtake partnerships; and Chris de Borst, Financial Controller. Mr. Spoeltman brings over 40 years of experience working for organizations such as Engie Belgium and RWE Generation NL in the areas of power generation, storage and distribution, with core competencies in renewable energy, liquified gas and cryogenic systems including LNG, LPG and Hydrogen. Mr. Lavalaye has spent 15 years working in the Dutch and Belgium energy market and has advised domestic and international customers on their purchase and consumption of renewable energy. He has extensive experience in preparing Power Purchase Agreements and previously was responsible for starting up the gas portfolio for Eneco in Belgium. Mr. de Borst joins VoltH2 from Orsted Netherlands where he was responsible for finance, IT and treasury and served as a board member of the offshore windfarm Borssele 1&2. He oversaw the growth of the organization from 6 to 60 employees within 24 months and assisted in the successful divestment of 50% of the Borssele portfolio for €1.5 billion.

Also recently hired are Gerwin Hament, Head of Project Management and Hans Brinkhof, Project Manager covering Germany. Mr. Hament has 20 years of experience in the energy markets with the last 10 years overseeing projects in the renewables market. Previously he has worked for Focus ON, Euroloop B.V. and E-On Benelux. Mr. Brinkhof is a Civil Engineer with over 30 years of experience as a technical manager across the construction and telecom sectors and has spent 25 years working in the Dutch Ministry of Infrastructure (RWS). The core team has developed and built wind, solar, biogas, biomass and CCGT energy projects, collectively worth over €4 billion Euros and will continue to work closely with the VoltH2 external engineering, technical and commercial partners to continue the successful development and delivery of the pioneering VoltH2 clean hydrogen production projects.

To accommodate the expanding team and to support operational coverage of a rapidly increasing inventory of project locations across the Benelux, France and Germany, VoltH2 has recently moved into new corporate head offices located in Bergen-op-Zoom, the Netherlands. This location is ideal due to its close proximity to the Belgium border and major road access to the Western borders of Germany. VoltH2 will continue to update on corporate and project development reflecting the most recent progress of VoltH2 as it continues to increase its footprint of clean hydrogen projects in Western Europe.

About VoltH2:

VoltH2 is in the business of designing, developing, building and operating green hydrogen plants in Europe. With two production facilities currently being developed in the Netherlands, both plants are forecasted to be in production in Q1 2023 with the capacity for each to produce 3.5 million kilograms of green hydrogen per year scalable to a combined 24.5 million kilograms per year. The strategic European location will allow for the green hydrogen to be transportable by road, rail and waterways. Local industries will be able to purchase green hydrogen to meet their environmental objectives. Please visit www.volth2.com for more information including the VoltH2 corporate presentation.

About Vision Hydrogen:

Vision Hydrogen Corporation is focused on hydrogen production for transportation and power requirements, with a goal of contributing to a clean-energy environment. Our commitment is to provide the highest-quality hydrogen production, storage and distribution services for the hydrogen economy supply chain, serving residential, commercial and government sectors.

Contact:

Vision Hydrogen Corporation/Investor Relations                                                
95 Christopher Columbus Drive, 16th Floor                                
Jersey City, NJ 07302                                                
551-298-3600 USA
www.visionh2.com

Corporate Communications:
InvestorBrandNetwork (IBN)
Los Angeles, California
www.InvestorBrandNetwork.com
310.299.1717 Office
Editor@InvestorBrandNetwork.com

Forward Looking Statements:

Certain statements in this press release are forward-looking within the meaning of the Private Securities Litigation Reform Act of 1995. These statements may be identified by the use of forward-looking words such as “anticipate,” “believe,” “forecast,” “estimate,” “expect” and “intend,” among others. These forward-looking statements are based on current expectations, and actual results could differ materially. The Company does not undertake an obligation to update or revise any forward-looking statement. The information set forth herein speaks only as of the date hereof.

To view this piece of content from www.globenewswire.com, please give your consent at the top of this page.
To view this piece of content from ml.globenewswire.com, please give your consent at the top of this page.

About GlobeNewswire by notified

GlobeNewswire by notified
GlobeNewswire by notified
One Liberty Plaza - 165 Broadway
NY 10006 New York

https://notified.com

GlobeNewswire by notified is one of the world's largest newswire distribution networks, specializing in the delivery of corporate press releases financial disclosures and multimedia content to the media, investment community, individual investors and the general public.

Subscribe to releases from GlobeNewswire by notified

Subscribe to all the latest releases from GlobeNewswire by notified by registering your e-mail address below. You can unsubscribe at any time.

Latest releases from GlobeNewswire by notified

Intervest Offices & Warehouses NV: Press release – Persbericht – Communiqué de presse: openbaarmaking over transparantiekennisgeving19.4.2024 18:00:00 CEST | Press release

Geachte mevrouw, meneer, Gelieve hierbij de links te vinden naar het recente persbericht van Intervest Offices & Warehouses betreffende de openbaarmaking over transparantiekennisgeving. Dear Madam, Sir, Please find hereunder the links to Intervest Offices & Warehouses’ latest press release regarding the publication of a transparency notification. Attachment NL_transparency notification_20240419

23/2024・Trifork Group AG – Shareholders approve all resolutions at the Annual General Meeting 202419.4.2024 17:34:19 CEST | Press release

Company announcement no. 23 / 2024 Schindellegi, Switzerland – 19 April 2024 Shareholders approve all resolutions at the Annual General Meeting 2024 The shareholders of Trifork Group AG (“Trifork“) today approved all resolutions proposed by the Board of Directors at Trifork’s Annual General Meeting 2024 (the “AGM“) which was held at Grabenstrasse 2, 6430 Baar, Switzerland. Dividend payment The shareholders approved the Board of Directors’ proposal to pay a gross dividend of EUR 0.10 per share (equivalent to CHF 0.10 per share) by making a payout from capital contribution reserves to the shareholders. The total gross dividend paid out amounts to CHFk 1,932, equivalent to DKKk 14,809, as calculated per the exchange rate published by the Swiss Federal Customs Administration as of 19 April 2024. The payout from capital contribution reserves is declared in CHF and paid out in DKK. Composition of the Board of Directors The shareholders re-elected Julie Galbo as Chairperson of the Board of Di

Havila Shipping ASA: Årsrapport 202319.4.2024 17:06:25 CEST | Pressemelding

Styret i Havila Shipping ASA har i dag godkjent regnskap og årsrapport for 2023 for konsern og morselskap. Resultatregnskap og balanser er i samsvar med foreløpig regnskap offentliggjort 27. februar 2024. Kontakter: Administrerende direktør Njål Sævik, +47 909 35 722 Finansdirektør Arne Johan Dale, +47 909 87 706 Denne opplysningen er informasjonspliktig etter verdipapirhandelloven §5-12 Vedlegg HAVI-20235967007LIEEXZXFJ8876-2023-12-31-no

Havila Shipping ASA : Annual Report 202319.4.2024 17:06:25 CEST | Press release

Today, the Board of Directors of Havila Shipping ASA has approved the financial statements for 2023 for both the Group and the parent company. The accounts are in line with preliminary accounts released on 27 February 2024. Contacts: Chief Executive Officer Njål Sævik, +47 909 35 722 Chief Financial Officer Arne Johan Dale, +47 909 87 706 This information is subject to the disclosure requirements pursuant to Section 5-12 the Norwegian Securities Trading Act Attachments HAVI-20235967007LIEEXZXFJ8876-2023-12-31-no

Transactions in Zealand Pharma shares and/or related securities by persons discharging managerial responsibilities and/or their closely associated persons19.4.2024 17:05:00 CEST | Press release

Company announcement – No. 23 / 2024 Transactions in Zealand Pharma shares and/or related securities by persons discharging managerial responsibilities and/or their closely associated persons Copenhagen, Denmark, April 19, 2024 – Zealand Pharma A/S (“Zealand”) (NASDAQ: ZEAL) (CVR-no. 20 04 50 78), a Copenhagen-based biotechnology company focused on the discovery and development of innovative peptide-based medicines, has received information on transactions in Zealand's shares or related securities conducted by persons discharging managerial responsibilities and/or their closely associated persons and hereby publishes the information on such transactions. Please see the attached file(s). # # # About Zealand Pharma A/S Zealand Pharma A/S (Nasdaq: ZEAL) ("Zealand") is a biotechnology company focused on the discovery and development of peptide-based medicines. More than 10 drug candidates invented by Zealand have advanced into clinical development, of which two have reached the market and

HiddenA line styled icon from Orion Icon Library.Eye